Tenet Healthcare (NYSE:THC) PT Raised to $147.00 at Barclays
Tenet Healthcare (NYSE:THC – Get Free Report) had its target price lifted by investment analysts at Barclays from $113.00 to $147.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective indicates a potential upside of 22.21% from the stock’s current […]